Universal molecular screening does not effectively detect Lynch syndrome in clinical practice

Mitali Fadia, Beatrice Brennan, Christine Hemmings, Ian Clark

    Research output: Contribution to journalArticlepeer-review

    25 Citations (Scopus)

    Abstract

    Background: Lynch syndrome (LS) due to an inherited damaging mutation in mismatch repair (MMR) genes comprises 3% of all incident colorectal cancer (CRC). Molecular testing using immunohistochemistry (IHC) for MMR proteins is a recommended screening tool to identify LS in incident CRC. This study assessed outcomes of population-based routine molecular screening for diagnosis of LS in a regional center. Methods: We conducted a prospective, consecutive case series study of universal IHC testing on cases of resected CRC from September 2004–December 2013. Referred cases with abnormal IHC results that attended a familial cancer clinic were assessed according to modified Bethesda criteria (until 2009) or molecular criteria (from 2009). Results: 1612 individuals underwent resection for CRC in the study period and had MMR testing by IHC. Of these, 274 cases (16.9%) exhibited loss of expression of MMR genes. The mean age at CRC diagnosis was 68.1 years ( ± standard deviation 12.7) and the mean age of those with an IHC abnormality was 71.6 ( ± 11.8). A total of 82 (29.9%) patients with an abnormal result were seen in a subspecialty familial cancer clinic. Patients aged under 50 ( p = 0.009) and those with loss of MSH6 staining ( p = 0.027) were more likely to be referred and to attend. After germ-line sequencing, 0.6% (10 of 82) were identified as having a clinically significant abnormality. A further eight probands with pathogenic germ-line mutations were identified from other referrals to the service over the same time period. Conclusions: While technically accurate, the yield of ‘universal’ IHC in detecting new Lynch probands is limited by real-world factors that reduce referrals and genetic testing. We propose an alternative approach for universal, incident case detection of Lynch syndrome with ‘one-stop’ MMR testing and sequencing.
    Original languageEnglish
    Pages (from-to)361-371
    JournalTherapeutic Advances in Gastroenterology
    Volume10
    Issue number4
    DOIs
    Publication statusPublished - 2017

    Fingerprint

    Dive into the research topics of 'Universal molecular screening does not effectively detect Lynch syndrome in clinical practice'. Together they form a unique fingerprint.

    Cite this